Compare NNNN & RTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | RTB |
|---|---|---|
| Founded | 2021 | 2022 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.1M | 128.6M |
| IPO Year | 2023 | 2008 |
| Metric | NNNN | RTB |
|---|---|---|
| Price | $3.81 | $5.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 45.9K | 28.4K |
| Earning Date | 11-24-2026 | 11-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,131,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.09 | $5.09 |
| 52 Week High | $44.73 | $20.75 |
| Indicator | NNNN | RTB |
|---|---|---|
| Relative Strength Index (RSI) | 43.58 | 26.50 |
| Support Level | $3.21 | N/A |
| Resistance Level | $6.95 | $9.00 |
| Average True Range (ATR) | 0.35 | 0.72 |
| MACD | 0.13 | -0.12 |
| Stochastic Oscillator | 42.92 | 3.64 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
RTB Digital Inc is focused on developing and operating a professional SaaS (Software as a Service) platform that hosts an exclusive coalition of professionally managed online media channels. Its operations include software development, advertising and sponsorship sales, and onboarding third-party content operators (Platform Partners) to publish content on the platform.